Editorial Commentary:Reassessing the Design, Conduct, and Analysis of Clinical Trials of Therapy for Community‐Acquired Pneumonia
Open Access
- 15 April 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (8) , 1152-1156
- https://doi.org/10.1086/533442
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community‐Acquired PneumoniaClinical Infectious Diseases, 2008
- Antibiotic Timing and Errors in Diagnosing PneumoniaArchives of internal medicine (1960), 2008
- Statistics in Medicine — Reporting of Subgroup Analyses in Clinical TrialsNew England Journal of Medicine, 2007
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- The Best Treatment for PneumoniaArchives of internal medicine (1960), 1999
- Quality of care, process, and outcomes in elderly patients with pneumoniaPublished by American Medical Association (AMA) ,1997
- Pneumococcic Segmental (Lobar) PneumoniaClinical Pediatrics, 1965
- Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal PneumoniaAnnals of Internal Medicine, 1964
- Massive Single-Dose Chemotherapy in Pneumonia in ChildrenActa Paediatrica, 1948
- Treatment of Pneumococcal Pneumonia with PenicillinNew England Journal of Medicine, 1945